Hayashi, Yoshinori
Ueyama, Azumi
Funaki, Soichiro
Jinushi, Koichi
Higuchi, Naoko
Morihara, Hitomi
Hirata, Michinari
Nagira, Yoji
Saito, Takuro
Kawashima, Atsunari
Iwahori, Kota
Shintani, Yasushi
Wada, Hisashi
Article History
Received: 18 March 2024
Accepted: 9 May 2024
First Online: 23 May 2024
Declarations
:
: This study was approved by the Institutional Review Board of Osaka University Hospital (approval number: 13266) and was performed in accordance with the Declaration of Hersinki. Informed consent was obtained from all patients.
: Not applicable.
: The Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University has a joint research laboratory with Shionogi & Co., Ltd.